Cite

HARVARD Citation

    Caminati, M. et al. (2016). Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience. BMC pulmonary medicine. 16 (1), pp. 1-9. [Online]. 
  
Back to record